Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Up 157.1% in July

Basel Medical Group Ltd (NASDAQ:BMGL) saw a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 32,559 shares, an increase of 157.1% from the June 30th total of 12,662 shares. Currently, 2.1% of the company’s stock are short sold. Based on an average daily volume of 70,687 shares, the days-to-cover ratio is presently 0.5 days.

Institutional Trading of Basel Medical Group

Institutional investors have recently modified their holdings of the company. Marex Group plc acquired a new position in shares of Basel Medical Group during the second quarter worth about $25,000. Virtu Financial LLC raised its position in Basel Medical Group by 108.8% in the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after buying an additional 17,608 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new stake in Basel Medical Group in the 3rd quarter valued at approximately $169,000.

Basel Medical Group Stock Up 1.9%

Shares of BMGL stock traded up $0.11 during trading hours on Monday, hitting $5.90. 5,661 shares of the company were exchanged, compared to its average volume of 28,979. Basel Medical Group has a 52 week low of $4.60 and a 52 week high of $27.36. The company has a quick ratio of 1.83, a current ratio of 1.88 and a debt-to-equity ratio of 0.93. The business has a 50 day moving average of $6.90 and a two-hundred day moving average of $7.52.

Basel Medical Group (NASDAQ:BMGL) last posted its quarterly earnings data on Friday, June 26th. The company reported $0.01 EPS for the quarter. The company had revenue of $3.21 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, July 16th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.